115 related articles for article (PubMed ID: 9291065)
1. Acquisition protocol for breast cancer imaging with technetium-99m-labeled synthetic peptide and technetium-99m-MDP.
Fiorenza M; Prisco G; Bartolomei M; Chinol M; Cremonesi M; Leonardi L; De Cicco C; Paganelli G
J Nucl Med Technol; 1997 Sep; 25(3):191-4. PubMed ID: 9291065
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
[TBL] [Abstract][Full Text] [Related]
3. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer.
Piccolo S; Lastoria S; Mainolfi C; Muto P; Bazzicalupo L; Salvatore M
J Nucl Med; 1995 May; 36(5):718-24. PubMed ID: 7738640
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic significance of 99mTc-MDP breast scintigraphy. A comparison with histological and molecular parameters].
Dimonte M; Leo G; Marsigliante S; Manca C
Radiol Med; 1999 Nov; 98(5):352-5. PubMed ID: 10780214
[TBL] [Abstract][Full Text] [Related]
7. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
Nishiyama Y; Yamamoto Y; Ono Y; Irie A; Yamauchi A; Satoh K; Ohkawa M
Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
[TBL] [Abstract][Full Text] [Related]
9. [Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results].
Cistaro A; Bonazzi G; Bellò M; Bessone M; Tetti M; Villata E; Coluccia C; Bisi G; Massaioli N
Minerva Chir; 1997 Oct; 52(10):1177-82. PubMed ID: 9471568
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of axillary lymph nodes from the results of radioisotopic study].
Rozhkova NI; Fomin DK; Smirnova NA; Mazo ML
Vestn Rentgenol Radiol; 2007; (5):13-5. PubMed ID: 18652188
[TBL] [Abstract][Full Text] [Related]
12. [A case of metastatic breast cancer showing extraosseous accumulation of 99mTc-HMDP in axillary lymph nodes on bone scintigraphy].
Endo H; Hashimoto T; Fujioka M; Murata K
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Nov; 61(13):730-2. PubMed ID: 11766398
[TBL] [Abstract][Full Text] [Related]
13. Impact of patient positioning in scintimammography.
Mirzaei S; Knoll P; Köhn H; Lipp RW; Zajicek SM
Eur J Nucl Med; 2001 Sep; 28(9):1437-8. PubMed ID: 11585308
[No Abstract] [Full Text] [Related]
14. Axillary lymph node uptake of technetium-99m-MDP.
Ongseng F; Goldfarb CR; Finestone H
J Nucl Med; 1995 Oct; 36(10):1797-9. PubMed ID: 7562045
[TBL] [Abstract][Full Text] [Related]
15. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.
Pijpers R; Meijer S; Hoekstra OS; Collet GJ; Comans EF; Boom RP; van Diest PJ; Teule GJ
J Nucl Med; 1997 Mar; 38(3):366-8. PubMed ID: 9074519
[TBL] [Abstract][Full Text] [Related]
16. [Complementary scintigraphic examinations (99mTc-MDP, 99mTc-MIBI and Octreoscan) in breast neoplasm assessment].
Stefănescu C; Chossiere L; Rusu V; Meignan M
Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):165-8. PubMed ID: 9455458
[TBL] [Abstract][Full Text] [Related]
17. [The value of 99mTc-MIBI image axillary lymph node in selecting operative method for breast cancer].
Qu X; Wang Y; Chen D; Li C
Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):41-3. PubMed ID: 11829776
[TBL] [Abstract][Full Text] [Related]
18. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-MDP patterns in patients with painful shoulder lesions.
Clunie G; Bomanji J; Ell PJ
J Nucl Med; 1997 Sep; 38(9):1491-5. PubMed ID: 9293816
[TBL] [Abstract][Full Text] [Related]
20. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]